Filter News
Area of Research
- (-) Nuclear Science and Technology (2)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (44)
- Clean Energy (32)
- Computational Biology (2)
- Computational Engineering (3)
- Computer Science (6)
- Fusion and Fission (5)
- Isotopes (5)
- Materials (21)
- Materials for Computing (3)
- Mathematics (1)
- National Security (28)
- Neutron Science (17)
- Quantum information Science (2)
- Supercomputing (56)
News Topics
- (-) Biomedical (2)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (10)
- Bioenergy (1)
- Computer Science (2)
- Coronavirus (1)
- Decarbonization (1)
- Fusion (8)
- Isotopes (5)
- Materials Science (3)
- Molten Salt (4)
- Neutron Science (4)
- Nuclear Energy (34)
- Physics (2)
- Space Exploration (5)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
![Solid radium sulfate sits in the bottom of a flask during the recovery process. Credit: Oak Ridge National Laboratory, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-06/Ac227%202.jpg?h=479d286c&itok=AiNceGva)
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.